DK30391A - Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel - Google Patents

Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel Download PDF

Info

Publication number
DK30391A
DK30391A DK030391A DK30391A DK30391A DK 30391 A DK30391 A DK 30391A DK 030391 A DK030391 A DK 030391A DK 30391 A DK30391 A DK 30391A DK 30391 A DK30391 A DK 30391A
Authority
DK
Denmark
Prior art keywords
cavitat
clatrate
substance consisting
guest complexes
contracting agent
Prior art date
Application number
DK030391A
Other languages
English (en)
Other versions
DK30391D0 (da
Inventor
Celal Albayrak
Georg Roessling
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK30391D0 publication Critical patent/DK30391D0/da
Publication of DK30391A publication Critical patent/DK30391A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/189—Host-guest complexes, e.g. cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/228—Host-guest complexes, clathrates, chelates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK030391A 1988-08-23 1991-02-21 Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel DK30391A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3828905A DE3828905A1 (de) 1988-08-23 1988-08-23 Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
PCT/DE1989/000548 WO1990001952A1 (de) 1988-08-23 1989-08-18 Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel

Publications (2)

Publication Number Publication Date
DK30391D0 DK30391D0 (da) 1991-02-21
DK30391A true DK30391A (da) 1991-02-21

Family

ID=6361599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK030391A DK30391A (da) 1988-08-23 1991-02-21 Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel

Country Status (12)

Country Link
EP (1) EP0357163B1 (da)
JP (1) JP3142539B2 (da)
AT (1) ATE76758T1 (da)
AU (1) AU641363B2 (da)
DE (2) DE3828905A1 (da)
DK (1) DK30391A (da)
ES (1) ES2042986T3 (da)
GR (1) GR3005457T3 (da)
IE (1) IE65168B1 (da)
NO (1) NO302101B1 (da)
PT (1) PT91501B (da)
WO (1) WO1990001952A1 (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (da) 1990-04-02 1993-05-01 Sint Sa
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
CA2112109A1 (en) * 1991-07-05 1993-01-21 Arne Berg Improvements in or relating to contrast agents
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
EP0605477B2 (en) * 1991-09-17 2007-06-20 GE Healthcare AS Gaseous ultrasound contrast media
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
CA2154590C (en) * 1993-01-25 2001-06-12 Steven C. Quay Phase shift colloids as ultrasound contrast agents
CN1061893C (zh) * 1993-03-08 2001-02-14 柯铭清 声学造影剂
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
DE69434119T3 (de) 1993-07-30 2011-05-05 Imcor Pharmaceutical Co., San Diego Stabilisierte mikrogasbläschen-zusammensetzungen für echographie
CA2154867C (en) * 1993-12-15 2007-05-29 Feng Yan Gas mixtures useful as ultrasound contrast media
US5545396A (en) * 1994-04-08 1996-08-13 The Research Foundation Of State University Of New York Magnetic resonance imaging using hyperpolarized noble gases
US5622687A (en) * 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
EP0766968B1 (en) * 1995-10-06 2001-01-17 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent
DE19543077C2 (de) * 1995-11-13 1997-10-16 Schering Ag Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel
PT904113E (pt) * 1996-03-05 2004-09-30 Acusphere Inc Gases fluorados microencapsulados para utilizacao como agentes de aquisicao de imagem
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
DE69736981D1 (de) 1996-05-01 2007-01-04 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6284222B1 (en) 1998-11-03 2001-09-04 Medi--Physics, Inc. Hyperpolarized helium-3 microbubble gas entrapment methods
DE19851605A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Mikropartikel enthaltendes Injektionsanästhesiemittel
JP4544551B2 (ja) * 1999-07-28 2010-09-15 日本曹達株式会社 トリ−ｏ−チモチド類を成分化合物とする分子化合物
WO2002045721A1 (en) * 2000-12-04 2002-06-13 Uws Ventures Limited Noble gas complexes
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3637926C1 (de) * 1986-11-05 1987-11-26 Schering Ag Ultraschall-Manometrieverfahren in einer Fluessigkeit mittels Mikroblaeschen

Also Published As

Publication number Publication date
IE65168B1 (en) 1995-10-04
EP0357163B1 (de) 1992-06-03
DK30391D0 (da) 1991-02-21
PT91501A (pt) 1990-03-08
AU4065189A (en) 1990-03-23
JP3142539B2 (ja) 2001-03-07
ATE76758T1 (de) 1992-06-15
JPH04501559A (ja) 1992-03-19
AU641363B2 (en) 1993-09-23
NO302101B1 (no) 1998-01-26
NO910711D0 (no) 1991-02-22
IE892685L (en) 1990-02-23
WO1990001952A1 (de) 1990-03-08
GR3005457T3 (da) 1993-05-24
DE58901585D1 (de) 1992-07-09
DE3828905A1 (de) 1990-03-15
ES2042986T3 (es) 1993-12-16
EP0357163A1 (de) 1990-03-07
NO910711L (no) 1991-02-22
PT91501B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
DK30391A (da) Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel
ES507527A0 (es) Perfeccionamientos en mesas de operaciones para la cirugia de manos.
NL194579B (nl) Diagnostisch middel.
NO161366C (no) Nye 1,3-cyklheksandion-derivater og anvendelse derav som herbicid middel.
DE3485162D1 (de) Als antibakterielle mittel verwendbare aminomethyloxooxazolidinyl-benzol-derivate.
IT8419216A0 (it) Strumento medico.
NO910399D0 (no) Anvendelse av trialkanolaminpolyetere som demulgatorer for olje-i-vann-emulsjoner.
DE59001418D1 (de) Antikoagulanz enthaltendes mittel.
SE7709328L (sv) Rontgenkontrastmedel
NO903863L (no) Tiazolidindionderivater som hypoglykemiske midler.
DK0557345T3 (da) 1,3-bis-(3-(mono- eller polyhydroxy)acylamino-5-(mono- eller polyhydroxyalkyl)aminocarbonyl-2,4,6- trijodbenzoylamino)-hydroxy- eller -hydroxyalkylpropaner, fremgangsmåder til fremstilling heraf samt røntgenkontrastmidler indeholdende disse
DK137945B (da) Trijodbenzenderivater til anvendelse som røntgenkontrastmidler.
DE69106138D1 (de) Spritzenvorrichtung für flüssigkeitsmischungen, insbesondere für zahnärztliche zwecke.
ITMI920955A1 (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
SE7811491L (sv) Ny polysackarid, forfarande for framstellning derav samt hypokolesterolkomposition innehallande den nya foreningen
NO901452D0 (no) Blandinger inneholdende 2-tiocyano-metyltio-benzotiazol for anvendelse som industrielle mikrobiocider.
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
NO162212C (no) Mykoherbicidkonsentrat, herbicid middel og anvendelse derav.
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
NO893847D0 (no) Dobbel pose for bruk som utvendig lunge.
DK137311B (da) Trijodbenzenderivater til anvendelse som røntgenkontrastmidler.
DK165789C (da) 4-oxo-4h-pyrimidooe2,1,aaaisoquinolinderivater, analogifremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse samt derivaterne til anvendelse som antiallergisk middel
FI910076A0 (fi) Paose foer foerbrukade, vid kirurgiska operationer anvaenda engaongsartiklar, saosom operationsdukar och kompresser.
DE3485217D1 (de) Blutdrucksenkende zusammensetzung.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment